GlassScriptPhysician profile
Keith L Probst
NPI 1316998446
$656.41
in general payments reported to CMS, 2019-2025
13 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $40.74 · 2021: $44.61 · 2022: $13.85 · 2024: $13.69 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $117 · Food and Beverage: $13.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $116.98 |
| Food and Beverage | $13.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $116.98 | 2025 | |
| Janssen Pharmaceuticals, INC | $108.94 | 2019 | |
| Novo Nordisk INC | $85.64 | 2019-2024 | Rybelsus, Ozempic |
| Amgen INC. | $83.44 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $65.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $53.30 | 2019-2020 | |
| Mannkind Corporation | $30.72 | 2021 | |
| Sunovion Pharmaceuticals INC. | $26.97 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $21.82 | 2019 | |
| Sanofi Pasteur INC. | $14.66 | 2019 | |
| Lilly USA, LLC | $13.85 | 2022 | |
| Medtronic Minimed, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Probst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.